By delineating its contributions to inflammation, fibrosis, cardiac remodeling, and endothelial dysfunction, our review underscores galectin-3’s significance in disease progression and highlights its potential as a target for innovative therapeutic interventions aimed at alleviating myocardial stiffness and preserving vascular function. The gene discussed is LGALS3; the disease is endothelial dysfunction.